chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm  felt tender and like she was being punched; Body aches in the elbows; arm  ached for days and she could hardly use the arm  because it hurt so bad, arm pain lasted much longer; Fever; This spontaneous case was reported by a nurse and describes the occurrence of TENDERNESS (arm  felt tender and like she was being punched), PAIN (Body aches in the elbows), PAIN IN EXTREMITY (arm  ached for days and she could hardly use the arm  because it hurt so bad, arm pain lasted much longer) and PYREXIA (Fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025220A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced TENDERNESS (arm  felt tender and like she was being punched), PAIN (Body aches in the elbows), PAIN IN EXTREMITY (arm  ached for days and she could hardly use the arm  because it hurt so bad, arm pain lasted much longer) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. On 31-Dec-2020, PAIN (Body aches in the elbows) and PYREXIA (Fever) had resolved. At the time of the report, TENDERNESS (arm  felt tender and like she was being punched) and PAIN IN EXTREMITY (arm  ached for days and she could hardly use the arm  because it hurt so bad, arm pain lasted much longer) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Narrative: COVID infections following completion of COVID vaccine series 05/28/21 COVID vaccine dose #1 (J&J( 07/25/21 Pt presents to screening reporting of cough, fatigue, sore throat; swabbed - COVID POSITIVE 08/01/21 Pt reports cough, diarrhea, loss of taste/smell, muscle pain that started 07/18, and new symptoms of runny nose, sore throat
Patient received the vaccine at 9:30 am and complained about feeling anxious and shivering  around 9:40 am. Her blood pressure was 174/95 mmHg. She also complained about chest tightness and breathing difficulty, so an EpiPen 0.3 mg auto-injector was administered into her left thigh at 9:45 am and EMS was contacted.
Woke up at 8AM (6/26/07) with pain in both legs as well as L arm. Difficulty walking secondary to pain, At times breathing fast and short of breath. Vomited x 1
Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
rt leg swollen & red, vomiting, uncontrollable crying, fever but not taken, parent said feel hot;instructed to take pt to ER, refused, but did call ER, cold packs & APAP given;sx subsided;
Breakthrough case admission after 4 vaccines Pfizer 3/18/21 lot# ER2613;  Pfizer 4/8/21 lot# EW0162;  pfizer 10/19/21 Lot# FF2590;  Pfizer 5/18/22 lot# FM7553
Pt received vaccines this morning, approx 1000 this am, home about 1045, pt went outside to play, at 1105 dad noticed pt looked red, 1115 dad saw some bumps on skin, called immun. clinic, instructed to call peds, instructed to come in upon arrival pt flushed? face to waist with large hives on trunk. Face, scattered hives on legs given Benadry 12.5mg/5mg tsp; no resp effort; pulse ox 99%, T 99, pulse 92, resp 24. Monitored x 2 hrs-released home.
Fever 101.8 continuing approx 6 hrs Headache Muscle ache
Myalgia, Arthralgia, Fever, UrticariPruritus, Nausea Vomitin, She also experienced fatigue. Her fever reached 105 degrees
One week after shot (March 4) I developed a rash at the shot site. It was red, slightly raised, and slightly itchy. I took benedryl and it seemed to subside. On  March 15 the area itched slightly and I saw a red ring that had extended well beyond the shot area. Saw my PCP that day and she was not concerned but suggested that I report it to you. I am told that the rash could persist for weeks.
Received TDAP and MCV4 11/5/2012. Fever of 101.9 F, headache, back ache, sore arm 11/6/2012. 11/7/2012 Lethargy, mild temp. 11/8/2012 Back to school.
Dizziness, fatigue, nausea began 2:00am on 8/8/06, Tylenol, Pepto Bismol given, Began feeling better at 9:00pm on 8/8/06.
Information has been received from a pharmacist referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history were not reported. On an unknown date the patient was vaccinated with RECOMBIVAX HB (lot # L023387 with expiration date 22-JUN-2017, strength, dose and route were unknown) that were improperly stored. No adverse effects reported. Additional information has been requested.
He has nerve pain down his arm to his hand from the injection site down to his pinky and also goes to the back of his neck making his hand weak and more difficult to do things.
At the moment I got a sore arms (left) in the evening I was having nausea and I was very energized, It seemed like I was given energy drink and I couldn't stop moving. the next day I was fatigue all day and after that I was with a sore day for almost a week, in that same week after the vaccination I got shingles I made appointment with MD, PhD he prescribed Acyclovir 800MG 4 daily for 40 days, Gabapentin 300MG daily for 40 days. on the 2nd week after the vaccination I went to My primary doctor at health center let him know about the shingles and I was advised to continue taking my medication I was prescribed my the two previous doctors.
arm is still getting bigger and bigger; hot; red; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm is still getting bigger and bigger), FEELING HOT (hot) and ERYTHEMA (red) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced PERIPHERAL SWELLING (arm is still getting bigger and bigger), FEELING HOT (hot) and ERYTHEMA (red). At the time of the report, PERIPHERAL SWELLING (arm is still getting bigger and bigger), FEELING HOT (hot) and ERYTHEMA (red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment medications were not provided.
Had full body joint aches, could not lie down to sleep due to the aches - took 600mg ibuprofen and that seemed to help. Felt better starting 7/6/18 and is able to move around better.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE OBSTRUCTIVE SLEEP APNEA 12/27/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This case was reported by a nurse via call center representative and described the occurrence of hives in a 7-year-old male patient who received FLUARIX QUADRIVALENT 2018-2019 season (batch number EN9S4, expiry date 30th June 2018) for prophylaxis. Previously administered products included FLUZONE (in 2012) and FLULAVAL (in 2015). On 25th September 2018, the patient received FLUARIX QUADRIVALENT 2018-2019 season. On 25th September 2018, immediately after receiving FLUARIX QUADRIVALENT 2018-2019 season, the patient experienced sickness. On an unknown date, the patient experienced hives (serious criteria hospitalization), shortness of breath (serious criteria hospitalization), wheezing (serious criteria hospitalization) and vomiting. The patient was treated with epinephrine, diphenhydramine hydrochloride (Benadryl Intravenous) and methylprednisolone sodium succinate (Solumedrol (Methyl Prednisolone)). On an unknown date, the outcome of the hives, shortness of breath, wheezing, vomiting and sickness were recovering/resolving. It was unknown if the reporter considered the hives, shortness of breath, wheezing, vomiting and sickness to be related to FLUARIX QUADRIVALENT 2018-2019 season. Additional details were reported as follows: The reporter stated that the patient had FLUZONE in 2012 and also had FLULAVAL in 2015 without any issues. After receiving FLUARIX QIV, the patient broke out in hives and got sick immediately. The patient also presented with vomiting, shortness of breath and wheezing. The patient was given epinephrine that seemed to work and was discharged from physician with oral medications. The patient ended up back in the hospital for 4 days due to the hives, shortness of breath and wheezing since none of the oral medications were working. The patient was given IV medications such as IV Benadryl and IV solumedrol which seemed to help. The patient was discharged from hospital after 4 days
A spontaneous report was received from a consumer concerning themselves, a male patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and developed body aches.  The patient's medical history was not provided. Concomitant product use was not provided.  The patient received one of two planned doses of mRNA-1273, injection site was not reported, for prophylaxis of COVID-19 infection.  The patient called in to report that they had body aches after administration of this vaccine.   Treatment for the event was not reported.   Action taken with mRNA-1273 was also not provided.  The outcome was unknown for event.; Reporter's Comments: This case concerns a male of unknown age who experienced NS unexpected event of pain. Event onset occurred with unknown latency after the first dose of mRNA-1273. Treatment not reported. Pain event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with GARDASIL (lot # not reported). Subsequently on an unspecified date, the patient "experienced a rash." The patient sought unspecified medical attention. This is one of several reports from the same source. Additional information has been requested.  07/08/2008 This is in follow-up to report(s) previously submitted on 5/14/2008. Initial and follow-up information has been received from a physician concerning a 17 year old female student with a history of childhood asthma and childhood pneumonia who on 19-JUN-2007 was vaccinated intramuscularly with a second dose of GARDASIL (lot # not reported). Subsequently on an unspecified date, the patient developed fatigue and abdominal pain, originally reported as "a rash". The patient sought unspecified medical attention. On an unspecified date the patient recovered. This is one of several reports from the same source. Initially the physician reported that the patient experienced a rash on an unspecified date. The patient outcome was unknown. Additional follow-up information received from the physician stated that on an unspecified date the patient experienced fatigue and abdominal pain. On an unspecified date the patient recovered from the fatigue and abdominal pain. No further information is expected.
Pain down back; Itchiness down back and neck; Pain in right arm and elbow; Welts on body (neck, shoulder, arm and back); Painful right shoulder blade; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BACK PAIN (Pain down back), PRURITUS (Itchiness down back and neck), PAIN IN EXTREMITY (Pain in right arm and elbow), URTICARIA (Welts on body (neck, shoulder, arm and back)) and ARTHRALGIA (Painful right shoulder blade) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031BZ1A4) for COVID-19 vaccination.     The patient's past medical history included Lung operation NOS (Lung surgery about 1 Year ago) in 2020. Concurrent medical conditions included Immune system disorder (Immune compromised).   On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced BACK PAIN (Pain down back), PRURITUS (Itchiness down back and neck), PAIN IN EXTREMITY (Pain in right arm and elbow), URTICARIA (Welts on body (neck, shoulder, arm and back)) and ARTHRALGIA (Painful right shoulder blade). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, BACK PAIN (Pain down back), PRURITUS (Itchiness down back and neck), PAIN IN EXTREMITY (Pain in right arm and elbow), URTICARIA (Welts on body (neck, shoulder, arm and back)) and ARTHRALGIA (Painful right shoulder blade) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement: elevated (High) Elevated.         No relevant concomitant medications were reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
right arm pain; full body aches; chills; slight temp; hot flashes; swollen right armpit tender to the touch; This is a spontaneous report from a contactable other healthcare professional (patient). A 42-years-old non-pregnant female patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EN5318), via intramuscular, administered in right arm on 18Feb2021 at 02:00 pm (42-year-old at the time of vaccination) as dose 2, single for covid-19 immunisation. The patient's medical history included  allergies to Sulfa, penicillin, milk intolerance and egg intolerance. Concomitant medication included loratadine, pseudoephedrine sulfate (CLARITIN-D) for unknown indication from unknown date and unknown if ongoing. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EL9261), via intramuscular, administered in right arm on 28Jan2021 at 01:00 pm (42-year-old at the time of vaccination) as dose 1, single for COVID-19 immunization and experienced hand tingling and medicine head feel for 30 mins with nausea occurring 2 days later. The patient had not received any vaccine within four weeks. The patient had no covid prior to vaccination. The patient was not tested since vaccination. On 19Feb 2021, at 20:00 (reported as 10PM), the patient experienced right arm pain, full body aches, chills, slight temp, and hot flashes, swollen right armpit tender to the touch. The patient stated that she woke on Saturday morning with a swollen right armpit tender to the touch and if pushed in would have increased soreness, while still with arm pain. The outcome of the events were recovering.   Follow-up attempts completed. No further information expected.
The first day I was very fatigued. Had a headache that lasted days. Caused my CFS/ME and mast cell activation to flare. Day 8 I got covid arm.
swelling at the injection site; itching at injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number BF4J5, expiry date 5th July 2021) for prophylaxis.   On 9th April 2019, the patient received the 2nd dose of Shingrix .5 ml. On 9th April 2019, less than a day after receiving Shingrix, the patient experienced injection site itching. On 11th April 2019, the patient experienced injection site swelling. On an unknown date, the outcome of the injection site swelling and injection site itching were not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling and injection site itching to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix on left arm. The patient started to itch at the injection site and still continues to itch.  On 11th April 2019, 2 days after vaccination the patient also developed swelling at the injection site.  The swelling is the size of a softball.
Redness at injection site; tenderness at injection site; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (tenderness at injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included CANDESARTAN CILEXETIL (ATACAND), ATORVASTATIN CALCIUM (LIPITOR), NAPHAZOLINE HYDROCHLORIDE (EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), PARACETAMOL (TYLENOL) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE PAIN (tenderness at injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness at injection site) had not resolved and VACCINATION SITE PAIN (tenderness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
feeling tired; feeling of melancholy was described as a feeling of rejection / escalated following both injections.; stomach issues / as a feeling of / being hungover / though she didn't drink alcohol; feeling of rejection; The blood in the stool presented after the 1st dose; stomach issues / described as a feeling of motion sickness; loose stool; headache; This case was reported by a consumer via call center representative and described the occurrence of blood in stool in a 60-year-old female patient who received SHINGRIX for prophylaxis.   On 30th July 2020, the patient received the 1st dose of SHINGRIX. On 31st July 2020, 1 days after receiving SHINGRIX, the patient experienced headache. In August 2020, the patient experienced blood in stool (serious criteria GSK medically significant), motion sickness and loose stools. On an unknown date, the patient experienced tiredness, feeling blue, hangover effect and feelings of worthlessness. On an unknown date, the outcome of the blood in stool was unknown and the outcome of the headache, tiredness, feeling blue, hangover effect, motion sickness, loose stools and feelings of worthlessness were recovered/resolved.   It was unknown if the reporter considered the blood in stool, headache, tiredness, feeling blue, hangover effect, motion sickness, loose stools and feelings of worthlessness to be related to SHINGRIX.  Additional details were provided as follows: The received SHINGRIX in left arm.  The patient experienced the same symptoms. The headache and feeling tired presented the day after the vaccination. A feeling of melancholy was described as a feeling of rejection. She was supposed to see her doctor for a physical and then was told she would not see her doctor but would receive the vaccine by a nurse. It left her feeling rejected and that feeling escalated following both injections. The stomach issues were described as a feeling of motion sickness or being hungover even though she didn't drink alcohol. The blood in the stool presented after the 1st dose only. The loose stool presented after both.  The stomach issues presented 2 to 3 days following both vaccines.  The reporter consent to follow up. For tolerance to 2nd dose refer linked case US2020193793, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020193793:same patient (2nd dose)
Today (2/28/18) developed spots noted by mother who wondered if related to VARIVAX given 16 days prior. Seen by Dr.who agreed. Approximately 18-20 papules pink, 2 with blebs.
Pt recvd vax 13MAY93 & on 15MAY93 c/o pain in lt arm; when mom examined arm it had an egg @ inject site; MD notified; 18MAY93 3" in diameter, arm was reddened, warm to touch, swollen, skin rough; no fever; rash hot to touch, bruised area;
Pharmacy administered Pfizer gray cap instead of Pfizer orange cap for patient. No adverse reaction after vaccine per mom.
Pt recvd Td vax & devel an abscess @ the site of inject;
First was mild.  I sat for 15 minutes after the shot and had a mild headache when I left.  I am not doing all this to report that. The following did not link up in my head as a possible side affect until this morning. Starting with Wednesday evening I was burning up.  (I am guessing at the 5pm I reported above).   I did not have a fever.  The burning up sensation was constant until I awoke this morning (Saturday).  It is only now I can tie it in with the burning sensations I got with M.S..  Thursday during my one class I kept making mistakes where I said one thing and wrote another.  Once is an accident.  10 times is MS.  I did connect that to MS even though I have not had that issue in over 10 years.  I thought it might be due to the small amount of sleep I got Wednesday night.  I now wonder if everything goes back to the shot.  I STILL WANT A SECOND SHOT.  I am just doing my due diligence in  reporting this for data purposes.  I was fine Friday except for the heat sensation in my skin and being tired.  The shot was worth it if it keeps Covid at bay.
headache, sore throat, nonproductive cough, fever, chills, body aches, sinus congestion, nasal congestion. starting 11/10/21
Unknown symptoms after second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Unknown symptoms after second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Unknown symptoms after second dose). At the time of the report, ADVERSE EVENT (Unknown symptoms after second dose) outcome was unknown.            No Concomitant medications were reported. No treatment medications were reported. Action taken with mRNA-1273 in response to the events were Not Applicable.    Reporter did not allow further contact